by dex.manley | Nov 9, 2023 | News
Lakeway, Texas (Date: 11-9-2023) – Vigilant Biosciences®, Inc. (“Vigilant”), an innovator and creator of solutions aimed at facilitating the early detection of oral cancer, is proud to announce the launch of its transformative product, the BeVigilant™...
by dex.manley | Oct 10, 2023 | News
As a pioneer in early oral cancer detection solutions, Vigilant Biosciences® strives to help clinicians diagnose oral cancer in Stages I and II to accelerate treatment initiation and improve patient outcomes. Our team leverages decades of specialized clinical...
by dex.manley | Oct 4, 2023 | News
Vigilant Biosciences® Leads the Charge Against Oral Cancer Lakeway, Texas (Oct. 4, 2023) – Vigilant Biosciences®, Inc. (“Vigilant”), an industry-leading developer of cutting-edge solutions that accelerate the detection of oral cancer, announces the release of its...
by dex.manley | Sep 19, 2023 | News
Dusseldorf, Germany (Sept. 19, 2023) – Vigilant Biosciences®, Inc. (“Vigilant”), a leading innovator and developer of solutions that assist in the early detection of oral cancer, announces the release of its breakthrough product, the BeVigilant™ OraFusion™ System, in...
by dex.manley | Sep 12, 2023 | News
Oral cancer is a steadily growing threat that impacts millions of lives across the world, with nearly half of cases resulting in death.1 Current estimates report that one in 60 men and one in 141 women in the U.S. will develop oral cancer during their lifetimes.2...
by dex.manley | Aug 1, 2023 | News
A missed cancer diagnosis can be devastating. However, unlike other malignancies, oral cancer is more likely to progress unnoticed until life-threatening stages. This is mainly due to misdiagnosis of early-stage signs and symptoms. One case review found that, among 35...
EN 
IT 
DE 
TR 
PT 
NL 
FR 
ES